logo

Equity Analysis

Company Profile
Detailed Quotes

Company News

    Saroja Pharma Industries India Ltd
    Industry :  Trading
    BSE Code
    ISIN Demat
    Book Value()
    91651
    INE0PCL01011
    36.4172043
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    SAROJA
    26.58
    23.3
    EPS(TTM)
    Face Value()
    Div & Yield %:
    2.18
    10
    0
     
John Cockerill India Ltd
John Cockerill India Ltd - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Jul 31,2024
Pursuant to Regulation 30 read with Schedule III Part A Para A (7) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform the decisions taken at the Companys Board Meeting held today i.e. July 30 2024 : Resignation of Mr. Kiran Rahate as the Chief Financial Officer and Key Managerial Personnel effective from close of working hours of September 30 2024. Appointment of Mr. Marc Dumont as the Chief Financial Officer and Key Managerial Personnel of the Company effective from October 1 2024. The relevant details as per the requirements of Regulation 30 of SEBI LODR read with SEBI Circular CIR/CFD/CMD/4/2015 dated September 9 2015 for the abvoe changes are given in the enclosed Annexure I.